insights_auto
Why is CYAD up 6,07%?
Dive Deeperchevron_right
CYAD:EBR
Celyad Oncology SA
0,23 €
arrow_upward
+6,07%(+0,013) 1D
16 қаз., 17:35:08 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYAD...
Open
0,21 €
High
0,23 €
Low
0,20 €
Mkt. cap
10,35 млн
Avg. vol.
11,20 мың
Volume
11,85 мың
P/E ratio
3,02
52-wk high
0,65 €
52-wk low
0,16 €
EPS
0,08 €
Shares outstanding
47,26 млн
No. of employees
5
Open
0,21 €
High
0,23 €
Low
0,20 €
Mkt. cap
10,35 млн
Avg. vol.
11,20 мың
Volume
11,85 мың
P/E ratio
3,02
52-wk high
0,65 €
52-wk low
0,16 €
EPS
0,08 €
Shares outstanding
47,26 млн
No. of employees
5
News stories
From web sources and news partners
KITV
·
47 минут бұрын
Nasdaq sinks more than 2% as investors raise questions about AI debt
MarketBeat
·
53 минут бұрын
Liberty Global (NASDAQ:LBTYA) Upgraded to Sell at Wall Street Zen
MarketBeat
·
53 минут бұрын
Silver Standard Resources (NASDAQ:SSRM) Stock Rating Cut to "Hold" at Wall Street Zen
MarketWatch
·
9 сағат бұрын
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
About Celyad Oncology SA
CEOFilippo Petti
Employees5
Founded2004
HeadquartersMont-Saint-Guibert, Walloon Brabant, Бельгия
Sector-
Websitecelyad.com